These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11732765

  • 1. Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy.
    Schwabe MJ, Wheless JW.
    J Child Neurol; 2001 Nov; 16(11):806-8. PubMed ID: 11732765
    [Abstract] [Full Text] [Related]

  • 2. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
    May TW, Rambeck B, Jürgens U.
    Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
    [Abstract] [Full Text] [Related]

  • 3. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Riva R, Albani F, Avoni P, Baruzzi A.
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [Abstract] [Full Text] [Related]

  • 4. Age and antiepileptic drugs influence topiramate plasma levels in children.
    Dahlin MG, Ohman IK.
    Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
    [Abstract] [Full Text] [Related]

  • 5. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E.
    Clin Pharmacokinet; 2005 Oct; 44(4):407-16. PubMed ID: 15828853
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG, Nandy P, Nye JS, Ford L, Mohanty S, Wang S, Ochalski S, Eerdekens M, Cox E.
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [Abstract] [Full Text] [Related]

  • 7. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R, Carpay J, Groselj J, van Oene J, Schreiner A, Lahaye M, Schwalen S, TOP-INT-51 Investigators' Group.
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [Abstract] [Full Text] [Related]

  • 8. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
    Ferrari AR, Guerrini R, Gatti G, Alessandrì MG, Bonanni P, Perucca E.
    Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056
    [Abstract] [Full Text] [Related]

  • 9. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy.
    Wheless JW, Neto W, Wang S, EPMN-105 Study Group.
    J Child Neurol; 2004 Feb; 19(2):135-41. PubMed ID: 15072107
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of topiramate in children younger than 2 years old.
    Valencia I, Fons C, Kothare SV, Khurana DS, Yum S, Hardison HH, Legido A.
    J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
    Zanotta N, Raggi ME, Radice L, Degrate A, Bresolin N, Zucca C.
    Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
    [Abstract] [Full Text] [Related]

  • 12. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial.
    Naritoku DK, Hulihan JF, Schwarzman LK, Kamin M, Olson WH.
    Ann Pharmacother; 2005 Mar; 39(3):418-23. PubMed ID: 15701778
    [Abstract] [Full Text] [Related]

  • 13. Topiramate: a new antiepileptic drug.
    Privitera MD.
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [Abstract] [Full Text] [Related]

  • 14. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD, Ben-Menachem E, Shank RP, Wiegand F.
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic interactions of topiramate.
    Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S.
    Clin Pharmacokinet; 2004 Feb; 43(12):763-80. PubMed ID: 15355124
    [Abstract] [Full Text] [Related]

  • 16. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM, Kriel RL, Leppik IE, White JR, Henry TR, Brundage RC, Cloyd JC.
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [Abstract] [Full Text] [Related]

  • 17. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E, Elger CE, Helmstaedter C.
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [Abstract] [Full Text] [Related]

  • 18. USL255 extended-release topiramate for the treatment of epilepsy.
    Chung S.
    Expert Rev Neurother; 2014 Oct; 14(10):1127-37. PubMed ID: 25220748
    [Abstract] [Full Text] [Related]

  • 19. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M, Yano I, Ito S, Sugimoto M, Yamamoto S, Yonezawa A, Ikeda A, Matsubara K.
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [Abstract] [Full Text] [Related]

  • 20. Topiramate serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and monitoring implications.
    Adín J, Gómez MC, Blanco Y, Herranz JL, Armijo JA.
    Ther Drug Monit; 2004 Jun; 26(3):251-7. PubMed ID: 15167623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.